Light-Induced Anti-Bacterial Effect Against Staphylococcus aureus of Porphyrin Covalently Bonded to a Polyethylene Terephthalate Surface.
Stefania F MusolinoFatima ShatilaGrace M O TiemanAnna C MasarskyMatthew C ThibodeauJeremy E WulffHeather L BuckleyPublished in: ACS omega (2022)
Antimicrobial photodynamic inactivation represents a promising and potentially greener alternative to conventional antimicrobials, and a solution for multidrug-resistant strains. The current study reports the development and characterization of tetra-substituted diazirine porphyrin covalently bonded to polyethylene terephthalate (PET) and its use as an antimicrobial surface. The diazirine moiety on the porphyrin was activated using a temperature of 120 °C, which initiated a C-H insertion mechanism that irreversibly functionalized the PET surface. Activation of the surface with white LED light in phosphate-buffered saline (PBS) led to singlet oxygen generation, which was detected via the degradation of 9,10-anthracenediylbis(methylene)dimalonic acid (ADMA) over time. The bactericidal effect of the 1 O 2 -producing surface against Staphylococcus aureus was determined qualitatively and quantitatively. The growth of the pathogen beneath porphyrin-functionalized PET coupons was reduced; moreover, the PET coupons resulted in a 1.76-log reduction in cell counts after exposure to white LED light for 6 h. This is a promising material and platform for the development of safer antimicrobial surfaces, with applications in healthcare, food packaging, marine surfaces, and other surfaces in the environment.
Keyphrases
- staphylococcus aureus
- biofilm formation
- photodynamic therapy
- pet ct
- computed tomography
- healthcare
- multidrug resistant
- positron emission tomography
- energy transfer
- pet imaging
- escherichia coli
- methicillin resistant staphylococcus aureus
- stem cells
- single cell
- quantum dots
- emergency department
- cell therapy
- risk assessment
- bone marrow
- molecular docking
- molecular dynamics simulations
- peripheral blood
- mass spectrometry
- drug delivery
- molecularly imprinted
- cystic fibrosis
- health insurance